XOMAP Q3 2017 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$309M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$36M+5598.1% YoY

Gross Profit

$35M97.2% margin

Operating Income

$29M79.2% margin

Net Income

$26M72.8% margin

EPS (Diluted)

$2.33

QoQ Revenue Growth

+232.3%

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

$31M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$50M

Total Liabilities

$46M

Stockholders' Equity

$4M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$635,000	+5598.1%
Gross Profit	$35M	-$8M	+537.6%
Operating Income	$29M	-$12M	+336.9%
Net Income	$26M	-$13M	+310.3%